The win ratio: Impact of censoring and follow‐up time and use with nonproportional hazards
- 31 October 2019
- journal article
- research article
- Published by Wiley in Pharmaceutical Statistics
- Vol. 19 (3) , 168-177
Abstract
The win ratio has been studied methodologically and applied in data analysis and in designing clinical trials. Researchers have pointed out that the results depend on follow‐up time and censoring time, which are sometimes used interchangeably. In this article, we distinguish between follow‐up time and censoring time, show theoretically the impact of censoring on the win ratio, and illustrate the impact of follow‐up time. We then point out that, if the treatment has long‐term benefit from a more important but less frequent endpoint (eg, death), the win ratio can show that benefit by following patients longer, avoiding masking by more frequent but less important outcomes, which occurs in conventional time‐to‐first‐event analyses. For the situation of nonproportional hazards, we demonstrate that the win ratio can be a good alternative to methods such as landmark survival rate, restricted mean survival time, and weighted log‐rank tests.Keywords
This publication has 25 references indexed in Scilit:
- The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical TrialsJAMA Oncology, 2016
- A win ratio approach to comparing continuous non‐normal outcomes in clinical trialsPharmaceutical Statistics, 2016
- Large sample inference for a win ratio analysis of a composite outcome based on prioritized componentsBiostatistics, 2015
- Robust bias estimation for Kaplan–Meier survival estimator with jackknifingJournal of Statistical Theory and Practice, 2015
- Nivolumab in Previously Untreated Melanoma withoutBRAFMutationNew England Journal of Medicine, 2015
- An Alternative Approach to Confidence Interval Estimation for the Win Ratio StatisticBiometrics, 2014
- Opportunities and challenges of combined effect measures based on prioritized outcomesStatistics in Medicine, 2013
- The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical prioritiesEuropean Heart Journal, 2011
- Generalized pairwise comparisons of prioritized outcomes in the two‐sample problemStatistics in Medicine, 2010
- Combining mortality and longitudinal measures in clinical trialsStatistics in Medicine, 1999